Brief: Viracta Therapeutics Reports First Quarter 2023 Financial Results And Provides Clinical Program Updates

Viracta Therapeutics

08/05/2023 23:30

May 8 (Reuters) - Viracta Therapeutics Inc  VIRX.O :
    * VIRACTA THERAPEUTICS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS AND PROVIDES CLINICAL PROGRAM UPDATES
    * CASH, CASH EQUIVALENTS AND INVESTMENTS OF $80.3 MILLION AS
OF
MARCH 31, 2023 PROVIDES ANTICIPATED CASH RUNWAY INTO LATE 2024
    * QTRLY LOSS PER SHARE $0.32
    * Q1 EARNINGS PER SHARE VIEW $-0.31 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNXbXdkcZ 
Further company coverage:  VIRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))